FNS  Vol.3 No.10 , October 2012
Dietary Factors Associated with Obesity in Patients with Schizophrenia Living at Home
Abstract: Since a fact-finding survey was conducted in 2005 all over Japan on the eating habits of psychiatric patients living at home, and the results showed that 44.6% of the patients were obese. We carried out a study of dietary factors associated with obesity in patients with schizophrenia living at home in order to develop a dietary education program. Twenty obese patients and 20 non-obese patients were randomly selected from 30 - 50s male patients with schizophrenia in one mental hospital. Dietary survey of 3-non-consecutive-day was conducted. Eighteen obese patients and 17 non-obese patients completed the survey. The obese patients had significantly higher intake of carbohydrate (P = 0.02), consumption of snacks with junk foods (P = 0.04), and intake of energy from snacks (P < 0.001) than those of non-obese patients. Based on this dietary survey, it becomes necessary to focus on snacks, in addition to basic focus on balanced diet to prevent further obesity in those schizophrenic patients.
Cite this paper: Y. Inamura, T. Izumi, K. Sakurai, T. Katsui and N. Murayama, "Dietary Factors Associated with Obesity in Patients with Schizophrenia Living at Home," Food and Nutrition Sciences, Vol. 3 No. 10, 2012, pp. 1387-1396. doi: 10.4236/fns.2012.310182.

[1]   Y. Inamura, T. Sagae, K. Nakamachi, M. Hirabayashi and K.Matsumura, “Seishinka Kanja No Taiingo No Shokuseikatsu Jittaichosa to Kadai,” Journal of JPHA, Vol. 25, No. 4, 2006, pp. 107-114.

[2]   T. Hideno, K. Asai and Y. Okubo, “Mansei Seishinbunretsubyo Kanja No Himan Taisaku,” Japanese Journal of Psychiatric Treatment, Vol. 12, No. 12, 1997, pp. 1423-1429.

[3]   H. Hoshino, “The Accelation of Appetite Weight Gain through the Process of Recovery for Schizophrenic Patients (from the Therapeutic Point of View),” Japanese Journal of Psychiatric Treatment, Vol. 12, No. 12, 1997, pp. 1431-1437.

[4]   Y. Inamura, “Seishinka Ni Okeru Eiyo Shokuji Sido Shokuseikatsu Sido Wo Kangaeru,” Journal of JPHA, Vol. 17, No. 9, 1998, pp. 906-911.

[5]   S. M. Stshl, “How to Appease the Appetite of Psychotropic Drugs,” Journal of Clinical Psychiatry, Vol. 59, No. 10, 1998, pp. 500-501. doi:10.4088/JCP.v59n1001

[6]   T. Wetterling and H. E. Musigbrodt, “Weight Gain: Side Effect of Atypical Neuroleptics,” Journal of Clinical Psychopharmacology, Vol. 19, No. 4, 1999, pp. 316-321. doi:10.1097/00004714-199908000-00006

[7]   H. Nasrallah, “A Review of the Effect of Atypical Antipsychotics on Weight,” Psychoneuroendocrinology, Vol. 28, 2003, pp. 83-96. doi:10.1016/S0306-4530(02)00114-2

[8]   D. C. Henderson, C. P. Borba , T. B. Daley, R. Boxill, D. D. Nguyen, et al., “Dietary Intake Profile of Patient with Schizophrenia,” Annals of Clinical Psychiatry, Vol. 18, No. 2, 2006, pp. 99-105. doi:10.1080/10401230600614538

[9]   S. Brown, J. Birtwistle, L. Roe and C. Thompson, “The Unhealthy Lifestyle of People with Schizophrenia,” Psychological Medicine, Vol. 29, No. 3, 1999, pp. 697-701. doi:10.1017/S0033291798008186

[10]   T. R. Kosten and D. M. Ziedonis, “Substance Abuse and Schizophrenics,” Schizophrenia Buiietim, Vol. 23, No. 2, 1997, pp. 181-186. doi:10.1093/schbul/23.2.181

[11]   D. A. Wirshing, W. C. Wirshing, L. Kysar, M. A. Berisford, D. Goldstein, et al., “Novel Antipsychotics: Comparison of Weight Gain Liabilities,” Journal of Clinical Psychopharmacology, Vol. 60, 1999, pp. 358-363. doi:10.4088/JCP.v60n0602

[12]   K. Sawamura and T. Someya, “Medication to Weight Gain Induced by Olanzapine and Quetiapine. H2 Antagonist,” Medicine Psychiatry Psychology, Vol. 52, No. 7, 2004, pp. 959-964.

[13]   T. Nagamine, “Shinki Koseishinbyoyaku Ni Mirareru Sintaigappeisho,” The Journal of Practical Pharmacy, Vol. 56, No.10, 2005, pp. 17-26.

[14]   J. Senba, “Shinki Koseishinbyoyaku No Tokucho,” The Journal of Practical Pharmacy, Vol. 56, No.10, 2005, pp. 3-11.

[15]   H. Okubo and S. Sasaki, “Underreporting of Energy Intake among Japanese Women Aged 18 20 Years and Its Association with Reported Nutrient and Food Group Intakes,” Public Health Nutrition, Vol. 7, No. 7, 2004, pp. 911-917. doi:10.1079/PHN2004635

[16]   M. B. Livingstone and A. E. Black, “Markers of the Validity of Reported Energy Intake,” Journal of Nutrition, Vol. 133, No. 3, 2003, pp. 895-920.

[17]   R. J. Hill and P. S. Davies, “The Validity of Self-Reported Energy Intakes as Determined Using the Doubly Labeled Water Technique,” British Journal of Nutrition, Vol. 85, No. 4, 2001, pp. 415-430. doi:10.1079/BJN2000281

[18]   J. Trabulsi and D. A. Schoeller, “Evaluation of Dietary Assessment Instruments against Doubly Labeled Water: A Biomarker of Habitual Energy Intake,” American Journal of Physiology—Endocrinology and Metabolism, Vol. 281, 2001, pp. 891-899.

[19]   S. Shimba, N. Ishii, Y. Ohta, T. Ohno, Y. Watabe, et al., “Brain and Muscle Arnt-Like Protein-1(BMAL1): A Component of the Molecular Clock, Regulates Adipogenesis,” Proceedings of the National Academy of Sciences of American, Vol. 102, No. 34, 2005, pp. 12071-12076. doi:10.1073/pnas.0502383102